46
464337AE4
Ionis Pharmaceuticals, Inc.
Could not find a ticker for this position, may be a filing error
A biotechnology company in Carlsbad, California, that makes RNA-targeted medicines using antisense technology — drugs that "turn off" disease-causing genes. Its best-known product is Spinraza, the first treatment for spinal muscular atrophy, developed with Biogen. Founded in 1989 as Isis Pharmaceuticals (named after the Egyptian goddess), it renamed itself Ionis in 2015 to shake off confusion with the terrorist group of the same name.
CONVERTIBLECUSIP: 464337AE4HealthcareUS1 derivative reporter
2.625% Convertible Subordinated Note due 2027
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
